<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39337343</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Implications of Dysnatremia and Endocrine Disturbances in COVID-19 Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9856</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms25189856</ELocationID><Abstract><AbstractText>Sodium imbalance is a common electrolyte disturbance in COVID-19, often linked to disruptions in hormonal regulation. This review explores the relationship between sodium dysregulation and endocrine disturbances, particularly focusing on primary and secondary hypothyroidism, hypocortisolism, and the renin-angiotensin-aldosterone system (RAAS). Hypocortisolism in COVID-19, due to adrenal insufficiency or secondary to pituitary dysfunction, can lead to hyponatremia through inadequate cortisol levels, which impair renal free water excretion and enhance antidiuretic hormone (ADH) secretion. Similarly, hypothyroidism is associated with decreased renal blood flow and the glomerular filtration rate (GFR), which also increases ADH activity, leading to water retention and dilutional hyponatremia. Furthermore, COVID-19 can disrupt RAAS (primarily through its interaction with the angiotensin-converting enzyme 2 (ACE2) receptor), diminishing aldosterone secretion and further contributing to sodium loss and hyponatremia. These hormonal disruptions suggest that sodium imbalance in COVID-19 is multifactorial and warrants further investigation into the complex interplay between COVID-19, endocrine function, and sodium homeostasis. Future research should focus on understanding these mechanisms to develop management algorithms that address both sodium imbalance and underlying hormonal disturbances in order to improve prognosis and outcomes in COVID-19 patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zlosa</LastName><ForeName>Mihaela</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0003-6131-3844</Identifier><AffiliationInfo><Affiliation>Clinic for Infectious Diseases, University Hospital Centre Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grubišić</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Clinic for Infectious Diseases, University Hospital Centre Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Švitek</LastName><ForeName>Luka</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0208-5821</Identifier><AffiliationInfo><Affiliation>Clinic for Infectious Diseases, University Hospital Centre Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectology and Dermatovenerology, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabadi</LastName><ForeName>Dario</ForeName><Initials>D</Initials><Identifier Source="ORCID">0009-0002-8283-6065</Identifier><AffiliationInfo><Affiliation>Clinic for Infectious Diseases, University Hospital Centre Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectology and Dermatovenerology, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Dental Medicine and Health Osijek, J. J. Strossmayer University of Osijek, 21 Crkvena Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canecki-Varžić</LastName><ForeName>Silvija</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Internal Medicine Clinic, University Hospital Centre Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mihaljević</LastName><ForeName>Ivica</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Clinical Institute of Nuclear Medicine and Radiation Protection, University Hospital Centre Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for Nuclear Medicine and Oncology, Faculty of Medicine, J. J. Strossmayer University of Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academy of Medical Sciences of Croatia, 15 Kaptol Street, HR-10000 Zagreb, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilić-Ćurčić</LastName><ForeName>Ines</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-8861-5987</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, Internal Medicine Clinic, University Hospital Centre Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kizivat</LastName><ForeName>Tomislav</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-2523-6007</Identifier><AffiliationInfo><Affiliation>Clinical Institute of Nuclear Medicine and Radiation Protection, University Hospital Centre Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department for Nuclear Medicine and Oncology, Faculty of Medicine, J. J. Strossmayer University of Osijek, 4 Josip Huttler Street, HR-31000 Osijek, Croatia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>IP 21-2024</GrantID><Agency>Faculty of Medicine Osijek, University of J.J. Strossmayer</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9NEZ333N27</RegistryNumber><NameOfSubstance UI="D012964">Sodium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012084" MajorTopicYN="Y">Renin-Angiotensin System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007010" MajorTopicYN="Y">Hyponatremia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004700" MajorTopicYN="N">Endocrine System Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012964" MajorTopicYN="N">Sodium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007037" MajorTopicYN="N">Hypothyroidism</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">adrenal gland</Keyword><Keyword MajorTopicYN="N">inappropriate ADH syndrome</Keyword><Keyword MajorTopicYN="N">pituitary gland</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">sodium imbalance</Keyword><Keyword MajorTopicYN="N">thyroid gland</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337343</ArticleId><ArticleId IdType="pmc">PMC11432667</ArticleId><ArticleId IdType="doi">10.3390/ijms25189856</ArticleId><ArticleId IdType="pii">ijms25189856</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marschalek R. SARS-CoV-2: The Virus, Its Biology and COVID-19 Disease-Counteracting Possibilities. Front. Biosci. Landmark. 2023;28:273. doi: 10.31083/j.fbl2810273.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.fbl2810273</ArticleId><ArticleId IdType="pubmed">37919074</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarker R., Roknuzzaman A.S.M., Nazmunnahar Shahriar M., Hossain M.J., Islam M.R. The WHO has declared the end of pandemic phase of COVID-19: Way to come back in the normal life. Health Sci. Rep. 2023;6:e1544. doi: 10.1002/hsr2.1544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.1544</ArticleId><ArticleId IdType="pmc">PMC10478644</ArticleId><ArticleId IdType="pubmed">37674622</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Ahmad Farouk I., Lal S.K. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2021;13:202. doi: 10.3390/v13020202.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020202</ArticleId><ArticleId IdType="pmc">PMC7911532</ArticleId><ArticleId IdType="pubmed">33572857</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M.Q., Lin H.F., Li J., Chen Y., Luo Y., Zhang W., Hu B., Tian F.J., Hu Y.J., Liu Y.J., et al. A SARS-CoV-2-Related Virus from Malayan Pangolin Causes Lung Infection without Severe Disease in Human ACE2-Transgenic Mice. J. Virol. 2023;97:e01719-22. doi: 10.1128/jvi.01719-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01719-22</ArticleId><ArticleId IdType="pmc">PMC9972989</ArticleId><ArticleId IdType="pubmed">36688655</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta P., Gupta V., Singh C.M., Singhal L. Emergence of COVID-19 Variants: An Update.  [(accessed on 9 May 2024)];Cureus. 2023 15:e41295. doi: 10.7759/cureus.41295. Available online:  https://www.cureus.com/articles/130199-emergence-of-covid-19-variants-an-update.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.41295</ArticleId><ArticleId IdType="pmc">PMC10394493</ArticleId><ArticleId IdType="pubmed">37539393</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J.Y., Smith D.M. SARS-CoV-2 Variants of Concern. Yonsei Med. J. 2021;62:961. doi: 10.3349/ymj.2021.62.11.961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2021.62.11.961</ArticleId><ArticleId IdType="pmc">PMC8542474</ArticleId><ArticleId IdType="pubmed">34672129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad A., Fawaz M.A., Aisha A. A comparative overview of SARS-CoV-2 and its variants of concern.  [(accessed on 5 May 2024)];Infez Med. 2022 30:328. Available online:  https://www.infezmed.it/media/journal/Vol_30_3_2022_2.pdf.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9448317</ArticleId><ArticleId IdType="pubmed">36148164</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Rosa Mesquita R., Francelino Silva Junior L.C., Santos Santana F.M., Farias De Oliveira T., Campos Alcântara R., Monteiro Arnozo G., da Silva Filho E.R., dos Santos A.G.G., da Cunha E.J.O., de Aquino S.H.H., et al. Clinical manifestations of COVID-19 in the general population: Systematic review. Wien. Klin. Wochenschr. 2021;133:377–382. doi: 10.1007/s00508-020-01760-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-020-01760-4</ArticleId><ArticleId IdType="pmc">PMC7689634</ArticleId><ArticleId IdType="pubmed">33242148</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Q., Liu J., Liu Q., Kang L., Liu R., Jing W., Wu Y., Liu M. Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis. JAMA Netw. Open. 2021;4:e2137257. doi: 10.1001/jamanetworkopen.2021.37257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.37257</ArticleId><ArticleId IdType="pmc">PMC8672238</ArticleId><ArticleId IdType="pubmed">34905008</ArticleId></ArticleIdList></Reference><Reference><Citation>Torabi S.H., Riahi S.M., Ebrahimzadeh A., Salmani F. Changes in symptoms and characteristics of COVID-19 patients across different variants: Two years study using neural network analysis. BMC Infect. Dis. 2023;23:838. doi: 10.1186/s12879-023-08813-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08813-9</ArticleId><ArticleId IdType="pmc">PMC10683353</ArticleId><ArticleId IdType="pubmed">38017395</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa Neto A.R.D., Carvalho A.R.B.D., Oliveira E.M.N.D., Magalhães R.D.L.B., Moura M.E.B., Freitas D.R.J.D. Symptomatic manifestations of the disease caused by coronavirus (COVID-19) in adults: Systematic review. Rev. Gaúcha Enferm. 2021;42:e20200205. doi: 10.1590/1983-1447.2021.20200205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1983-1447.2021.20200205</ArticleId><ArticleId IdType="pubmed">34037180</ArticleId></ArticleIdList></Reference><Reference><Citation>He X., Cheng X., Feng X., Wan H., Chen S., Xiong M. Clinical Symptom Differences Between Mild and Severe COVID-19 Patients in China: A Meta-Analysis. Front. Public Health. 2021;8:561264. doi: 10.3389/fpubh.2020.561264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.561264</ArticleId><ArticleId IdType="pmc">PMC7841395</ArticleId><ArticleId IdType="pubmed">33520906</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgieva E., Ananiev J., Yovchev Y., Arabadzhiev G., Abrashev H., Abrasheva D., Atanasov V., Kostandieva R., Mitev M., Petkova-Parlapanska K., et al. COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction. Int. J. Mol. Sci. 2023;24:14876. doi: 10.3390/ijms241914876.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241914876</ArticleId><ArticleId IdType="pmc">PMC10573237</ArticleId><ArticleId IdType="pubmed">37834324</ArticleId></ArticleIdList></Reference><Reference><Citation>Soraya G.V., Ulhaq Z.S. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: An updated meta-analysis. Med. Clin. 2020;155:143–151. doi: 10.1016/j.medcli.2020.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medcli.2020.05.017</ArticleId><ArticleId IdType="pmc">PMC7274591</ArticleId><ArticleId IdType="pubmed">32586670</ArticleId></ArticleIdList></Reference><Reference><Citation>Zahedi M., Kordrostami S., Kalantarhormozi M., Bagheri M. A Review of Hyperglycemia in COVID-19. Cureus. 2023;15 doi: 10.7759/cureus.37487.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.37487</ArticleId><ArticleId IdType="pmc">PMC10181889</ArticleId><ArticleId IdType="pubmed">37187644</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima-Martínez M.M., Boada C.C., Silva M., Marín W., Contreras M. COVID-19 and diabetes: A bidirectional relationship. Clin. Investig. Arterioscler. 2021;33:151–157. doi: 10.1016/j.artere.2021.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artere.2021.04.004</ArticleId><ArticleId IdType="pmc">PMC7598432</ArticleId><ArticleId IdType="pubmed">33303218</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K., Del Prato S., Mathieu C., Kahn S.E., Gabbay R.A., Buse J.B. COVID-19, Hyperglycemia, and New-Onset Diabetes. Diabetes Care. 2021;44:2645–2655. doi: 10.2337/dc21-1318.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1318</ArticleId><ArticleId IdType="pmc">PMC8669536</ArticleId><ArticleId IdType="pubmed">34625431</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho H., Richard M.C., Chouihed T., Goffinet N., Le Bastard Q., Freund Y., Kratz A., Dubroux M., Masson D., Figueres L., et al. Electrolyte imbalance in COVID-19 patients admitted to the Emergency Department: A case–control study. Intern. Emerg. Med. 2021;16:1945–1950. doi: 10.1007/s11739-021-02632-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02632-z</ArticleId><ArticleId IdType="pmc">PMC7823192</ArticleId><ArticleId IdType="pubmed">33484453</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal A., Zafra M.A., Simón M.J., Mahía J. Sodium Homeostasis, a Balance Necessary for Life. Nutrients. 2023;15:395. doi: 10.3390/nu15020395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15020395</ArticleId><ArticleId IdType="pmc">PMC9862583</ArticleId><ArticleId IdType="pubmed">36678265</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahkuri S., Becker T., Schueller V., Massberg S., Bauer-Mehren A. Prior fluid and electrolyte imbalance is associated with COVID-19 mortality. Commun. Med. 2021;1:51. doi: 10.1038/s43856-021-00051-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-021-00051-x</ArticleId><ArticleId IdType="pmc">PMC9053234</ArticleId><ArticleId IdType="pubmed">35602191</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J., Yuan N., Huang Z., Hu Z., Bao Q., Shao Z., Mei Q., Xu Y., Wang W., Liu D., et al. Assessment of hypokalemia and clinical prognosis in Patients with COVID-19 in Yangzhou, China. PLoS ONE. 2022;17:e0271132. doi: 10.1371/journal.pone.0271132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0271132</ArticleId><ArticleId IdType="pmc">PMC9269409</ArticleId><ArticleId IdType="pubmed">35802669</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin A., Moon R., Agiro A., Rosenthal N., Brown H., Legg R., Pottorf W. In-hospital mortality, length of stay, and hospitalization cost of COVID-19 patients with and without hyperkalemia. Am. J. Med. Sci. 2022;364:444–453. doi: 10.1016/j.amjms.2022.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2022.04.029</ArticleId><ArticleId IdType="pmc">PMC9050185</ArticleId><ArticleId IdType="pubmed">35490703</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheorghe G., Ilie M., Bungau S., Stoian A.M.P., Bacalbasa N., Diaconu C.C. Is There a Relationship between COVID-19 and Hyponatremia? Medicina. 2021;57:55. doi: 10.3390/medicina57010055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57010055</ArticleId><ArticleId IdType="pmc">PMC7827825</ArticleId><ArticleId IdType="pubmed">33435405</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Zhang S., Dong X., Li Z., Xu Q., Feng H., Cai J., Huang S., Guo J., Zhang L., et al. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome. J. Clin. Investig. 2020;130:6417–6428. doi: 10.1172/JCI140617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140617</ArticleId><ArticleId IdType="pmc">PMC7685724</ArticleId><ArticleId IdType="pubmed">33141117</ArticleId></ArticleIdList></Reference><Reference><Citation>RECOVERY Collaborative Group Dexamethasone in Hospitalized Patients with COVID-19. N. Engl. J. Med. 2021;384:693–704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhou Y.J.J., Hor A., Wang M., Wu Y.-F., Jose S., Chipps D.R., Cheung N.W. Dexamethasone-induced hyperglycaemia in COVID-19: Glycaemic profile in patients without diabetes and factors associated with hyperglycaemia. Diabetes Res. Clin. Pract. 2022;194:110151. doi: 10.1016/j.diabres.2022.110151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2022.110151</ArticleId><ArticleId IdType="pmc">PMC9651935</ArticleId><ArticleId IdType="pubmed">36375566</ArticleId></ArticleIdList></Reference><Reference><Citation>Babajani F., Kakavand A., Mohammadi H., Sharifi A., Zakeri S., Asadi S., Afshar Z.M., Rahimi Z., Sayad B. COVID-19 and renin angiotensin aldosterone system: Pathogenesis and therapy. Health Sci. Rep. 2021;4:e440. doi: 10.1002/hsr2.440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.440</ArticleId><ArticleId IdType="pmc">PMC8596942</ArticleId><ArticleId IdType="pubmed">34869917</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancia G., Rea F., Ludergnani M., Apolone G., Corrao G. Renin-Angiotensin-Aldosterone System Blockers and the Risk of COVID-19. N. Engl. J. Med. 2020;382:2431–2440. doi: 10.1056/NEJMoa2006923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2006923</ArticleId><ArticleId IdType="pmc">PMC7206933</ArticleId><ArticleId IdType="pubmed">32356627</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds H.R., Adhikari S., Pulgarin C., Troxel A.B., Iturrate E., Johnson S.B., Hausvater A., Newman J.D., Berger J.S., Bangalore S., et al. Renin-Angiotensin-Aldosterone System Inhibitors and Risk of COVID-19. N. Engl. J. Med. 2020;382:2441–2448. doi: 10.1056/NEJMoa2008975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2008975</ArticleId><ArticleId IdType="pmc">PMC7206932</ArticleId><ArticleId IdType="pubmed">32356628</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S., Casaro E.B., Rangel É.B. COVID-19: Angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur. J. Clin. Microbiol. Infect Dis. 2021;40:905–919. doi: 10.1007/s10096-020-04138-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino A., Hasenmajer V., Newell-Price J., Isidori A.M. COVID-19 pandemic and adrenals: Deep insights and implications in patients with glucocorticoid disorders. Endocrine. 2023;82:1–14. doi: 10.1007/s12020-023-03411-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-023-03411-w</ArticleId><ArticleId IdType="pmc">PMC10462567</ArticleId><ArticleId IdType="pubmed">37338722</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y., Xu B., Guan W., Xu D., Li F., Ren R., Zhu X., Gao Y., Jiang L. The Adrenal Cortex, an Underestimated Site of SARS-CoV-2 Infection. Front. Endocrinol. 2020;11:593179. doi: 10.3389/fendo.2020.593179.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.593179</ArticleId><ArticleId IdType="pmc">PMC7820749</ArticleId><ArticleId IdType="pubmed">33488517</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwahara K. The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications. Pharmacol. Ther. 2021;227:107863. doi: 10.1016/j.pharmthera.2021.107863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2021.107863</ArticleId><ArticleId IdType="pubmed">33894277</ArticleId></ArticleIdList></Reference><Reference><Citation>Fountain J.H., Kaur J., Lappin S.L.  StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2024.  [(accessed on 24 August 2024)]. Physiology, Renin Angiotensin System. Available online:  http://www.ncbi.nlm.nih.gov/books/NBK470410/</Citation><ArticleIdList><ArticleId IdType="pubmed">29261862</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuzzo B., Padala S.A., Lappin S.L.  StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA:  [(accessed on 24 August 2024)]. Physiology, Vasopressin. Available online:  http://www.ncbi.nlm.nih.gov/books/NBK526069/</Citation><ArticleIdList><ArticleId IdType="pubmed">30252325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira N.S., Tostes R.C., Paradis P., Schiffrin E.L. Aldosterone, Inflammation, Immune System, and Hypertension. Am. J. Hypertens. 2021;34:15–27. doi: 10.1093/ajh/hpaa137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajh/hpaa137</ArticleId><ArticleId IdType="pmc">PMC7891246</ArticleId><ArticleId IdType="pubmed">32820797</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehrabadi M.E., Hemmati R., Tashakor A., Homaei A., Yousefzadeh M., Hemati K., Hosseinkhani S. Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity. Biomed. Pharmacother. 2021;137:111363. doi: 10.1016/j.biopha.2021.111363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111363</ArticleId><ArticleId IdType="pmc">PMC7862910</ArticleId><ArticleId IdType="pubmed">33582450</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirza S.A., Sheikh A.A.E., Barbera M., Ijaz Z., Javaid M.A., Shekhar R., Pal S., Sheikh A.B. COVID-19 and the Endocrine System: A Review of the Current Information and Misinformation. Infect. Dis. Rep. 2022;14:184–197. doi: 10.3390/idr14020023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/idr14020023</ArticleId><ArticleId IdType="pmc">PMC8938795</ArticleId><ArticleId IdType="pubmed">35314653</ArticleId></ArticleIdList></Reference><Reference><Citation>Oguz S.H., Yildiz B.O. Endocrine Disorders and COVID-19. Annu. Rev. Med. 2023;74:75–88. doi: 10.1146/annurev-med-043021-033509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-043021-033509</ArticleId><ArticleId IdType="pubmed">36151047</ArticleId></ArticleIdList></Reference><Reference><Citation>lvarez-Troncoso J., Zapatero Larrauri M., Montero Vega M.D., Gil Vallano R., Palmier Peláez E., Martín Rojas-Marcos P., Martín-Luengo F., del Campo P.L., Gil C.R.H., Esteban E.T. Case Report: COVID-19 with Bilateral Adrenal Hemorrhage. Am. J. Trop. Med. Hyg. 2020;103:1156–1157. doi: 10.4269/ajtmh.20-0722.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0722</ArticleId><ArticleId IdType="pmc">PMC7470557</ArticleId><ArticleId IdType="pubmed">32682452</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkhouly M.M., Elazzab A.A., Moghul S.S. Bilateral adrenal hemorrhage in a man with severe COVID-19 pneumonia. Radiol. Case Rep. 2021;16:1438–1442. doi: 10.1016/j.radcr.2021.03.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.radcr.2021.03.032</ArticleId><ArticleId IdType="pmc">PMC7998055</ArticleId><ArticleId IdType="pubmed">33815638</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossetti C.L., Cazarin J., Hecht F., Beltrão F.E.D.L., Ferreira A.C.F., Fortunato R.S., Ramos H.E., de Carvalho D.P. COVID-19 and thyroid function: What do we know so far? Front. Endocrinol. 2022;13:1041676. doi: 10.3389/fendo.2022.1041676.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.1041676</ArticleId><ArticleId IdType="pmc">PMC9806267</ArticleId><ArticleId IdType="pubmed">36601011</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramczyk U., Nowaczyński M., Słomczyński A., Wojnicz P., Zatyka P., Kuzan A. Consequences of COVID-19 for the Pancreas. Int. J. Mol. Sci. 2022;23:864. doi: 10.3390/ijms23020864.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23020864</ArticleId><ArticleId IdType="pmc">PMC8776154</ArticleId><ArticleId IdType="pubmed">35055050</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng W., Bao L., Song Z., Zhang L., Yu P., Xu Y., Wang J., Zhao W., Zhang X., Han Y., et al. Infection with SARS-CoV-2 can cause pancreatic impairment. Sig. Transduct. Target Ther. 2024;9:98. doi: 10.1038/s41392-024-01796-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-024-01796-2</ArticleId><ArticleId IdType="pmc">PMC11014980</ArticleId><ArticleId IdType="pubmed">38609366</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechmann N., Maccio U., Kotb R., Dweik R.A., Cherfane M., Moch H., Bornstein S.R., Varga Z. COVID-19 Infections in Gonads: Consequences on Fertility? Horm. Metab. Res. 2022;54:549–555. doi: 10.1055/a-1891-6621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1891-6621</ArticleId><ArticleId IdType="pmc">PMC9363149</ArticleId><ArticleId IdType="pubmed">35853464</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaikkakara S., Raj M.N., Sachan A., Mohan A., Vengamma B., Rao P.V.L.N.S., Mukka A., Sravani C., Reddy A.P. Impact of Severity of Illness on the Function of the Hypothalamo-pituitary-gonadal Axis in Postmenopausal Women with Acute Severe Illness: Implications for Predicting Disease Outcome. Indian J. Endocrinol. Metab. 2017;21:738–744. doi: 10.4103/ijem.IJEM_398_16.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijem.IJEM_398_16</ArticleId><ArticleId IdType="pmc">PMC5628547</ArticleId><ArticleId IdType="pubmed">28989885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferro B., Bernardeschi G., Mori R., Abramo A., Giunta F. Sexual hormone pattern in chronic critically ill patients. Crit. Care. 2009;13((Suppl. 1)):P458. doi: 10.1186/cc7622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7622</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutinho L.M., Clemenza S., Campana D., Petraglia F.  The Menstrual Disorders Related to Systemic Diseases. In: Petraglia F., Fauser B.C., editors. Female Reproductive Dysfunction. Springer International Publishing; Cham, Switzerland: 2020.  [(accessed on 27 August 2024)]. pp. 85–94. Available online:  https://link.springer.com/10.1007/978-3-030-14782-2_5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-14782-2_5</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal R. COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Endocrine. 2020;68:251–252. doi: 10.1007/s12020-020-02325-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02325-1</ArticleId><ArticleId IdType="pmc">PMC7186765</ArticleId><ArticleId IdType="pubmed">32346813</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbova N.Y., Vladimirova V.P., Rozhinskaya L.Y., Belaya Z.Y. Hypophysitis and reversible hypopituitarism developed after COVID-19 infection—A clinical case report. Probl. Endokrinol. 2022;68:50–56. doi: 10.14341/probl12896.</Citation><ArticleIdList><ArticleId IdType="doi">10.14341/probl12896</ArticleId><ArticleId IdType="pmc">PMC9762539</ArticleId><ArticleId IdType="pubmed">35841168</ArticleId></ArticleIdList></Reference><Reference><Citation>Misgar R.A., Rasool A., Wani A.I., Bashir M.I. Central diabetes insipidus (Infundibuloneuro hypophysitis): A late complication of COVID-19 infection. J. Endocrinol. Investig. 2021;44:2855–2856. doi: 10.1007/s40618-021-01627-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-021-01627-z</ArticleId><ArticleId IdType="pmc">PMC8253675</ArticleId><ArticleId IdType="pubmed">34215999</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajevac H., Bachan M., Khan Z. Diabetes Insipidus as A Symptom of COVID-19 Infection: Case Report. Chest. 2020;158:A2576. doi: 10.1016/j.chest.2020.09.172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.09.172</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh A.B., Javed N., Sheikh A.A.E., Upadhyay S., Shekhar R. Diabetes Insipidus and Concomitant Myocarditis: A Late Sequelae of COVID-19 Infection. J. Investig. Med. High Impact Case Rep. 2021;9:232470962199995. doi: 10.1177/2324709621999954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2324709621999954</ArticleId><ArticleId IdType="pmc">PMC7952841</ArticleId><ArticleId IdType="pubmed">33686899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S.S., Kumar K., Venkataramani S., Ghazi N.M. Central Diabetes Insipidus: An Acute Manifestation of COVID-19 Infection. Cureus. 2023;15:e43884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10511668</ArticleId><ArticleId IdType="pubmed">37746393</ArticleId></ArticleIdList></Reference><Reference><Citation>Murvelashvili N., Tessnow A. A Case of Hypophysitis Following Immunization With the mRNA-1273 SARS-CoV-2 Vaccine. J. Investig. Med. High Impact Case Rep. 2021;9:23247096211043386. doi: 10.1177/23247096211043386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23247096211043386</ArticleId><ArticleId IdType="pmc">PMC8474296</ArticleId><ArticleId IdType="pubmed">34553641</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Z., Zhong J., Jiang Y., Zhang J. Associations between COVID-19 infection and sex steroid hormones. Front. Endocrinol. 2022;13:940675. doi: 10.3389/fendo.2022.940675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.940675</ArticleId><ArticleId IdType="pmc">PMC9592769</ArticleId><ArticleId IdType="pubmed">36303865</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Xie W., Li D., Shi L., Ye G., Mao Y., Xiong Y., Sun H., Zheng F., Chen Z., et al. Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. J. Med. Virol. 2021;93:456–462. doi: 10.1002/jmv.26259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26259</ArticleId><ArticleId IdType="pmc">PMC7361404</ArticleId><ArticleId IdType="pubmed">32621617</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan N., Behan L.A., Owens L. The Impact of the COVID-19 Pandemic on Women’s Reproductive Health. Front. Endocrinol. 2021;12:642755. doi: 10.3389/fendo.2021.642755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2021.642755</ArticleId><ArticleId IdType="pmc">PMC8030584</ArticleId><ArticleId IdType="pubmed">33841334</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra A., Verbakel J.Y., Kasaven L.S., Tzafetas M., Grewal K., Jones B., Bennett P.R., Kyrgiou M., Saso S. The menstrual cycle and the COVID-19 pandemic. PLoS ONE. 2023;18:e0290413. doi: 10.1371/journal.pone.0290413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0290413</ArticleId><ArticleId IdType="pmc">PMC10566721</ArticleId><ArticleId IdType="pubmed">37819943</ArticleId></ArticleIdList></Reference><Reference><Citation>Błażejewski G., Witkoś J. The Impact of COVID-19 on Menstrual Cycle in Women. J. Clin. Med. 2023;12:4991. doi: 10.3390/jcm12154991.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12154991</ArticleId><ArticleId IdType="pmc">PMC10419606</ArticleId><ArticleId IdType="pubmed">37568393</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasi V.D., Rastrelli G. The Role of Sex Hormones in the Disparity of COVID-19 Outcomes Based on Gender. J. Sex. Med. 2021;18:1950–1954. doi: 10.1016/j.jsxm.2021.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsxm.2021.09.003</ArticleId><ArticleId IdType="pmc">PMC8429355</ArticleId><ArticleId IdType="pubmed">34645593</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshari P., Zakerkish M., Abedi P., Beheshtinasab M., Maraghi E., Meghdadi H. Effect of COVID-19 infection on sex hormone levels in hospitalized patients: A prospective longitudinal study in Iran. Health Sci. Rep. 2023;6:e1011. doi: 10.1002/hsr2.1011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hsr2.1011</ArticleId><ArticleId IdType="pmc">PMC9789677</ArticleId><ArticleId IdType="pubmed">36582631</ArticleId></ArticleIdList></Reference><Reference><Citation>Salciccia S., Moriconi M., Asero V., Canale V., Eisenberg M.L., Glover F., Belladelli F., Seranio N., Basran S., De Berardinis E., et al. Systematic review and meta-analysis of serum total testosterone and luteinizing hormone variations across hospitalized COVID-19 patients. Sci. Rep. 2024;14:1–11. doi: 10.1038/s41598-024-53392-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-53392-7</ArticleId><ArticleId IdType="pmc">PMC10837199</ArticleId><ArticleId IdType="pubmed">38307934</ArticleId></ArticleIdList></Reference><Reference><Citation>Spratt D.I., Bigos S.T., Beitins I., Cox P., Longcope C., Orav J. Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: Bio- and immunoactive gonadotropins. J. Clin. Endocrinol. Metab. 1992;75:1562–1570.</Citation><ArticleIdList><ArticleId IdType="pubmed">1464665</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques C.A., Almeida P.P., Gonçalves A.M., Nagirnyak V., Cabeleira J. COVID-19 and Adrenal Insufficiency: Unmasking the Link. Cureus. 2023;15:e47920. doi: 10.7759/cureus.47920.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.47920</ArticleId><ArticleId IdType="pmc">PMC10684291</ArticleId><ArticleId IdType="pubmed">38034146</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakhshoori M., Heidarpour M., Bondariyan N., Sadeghpour N., Mousavi Z. Adrenal Insufficiency in Coronavirus Disease 2019 (COVID-19)-Infected Patients without Preexisting Adrenal Diseases: A Systematic Literature Review. Int. J. Endocrinol. 2021;2021:1–8. doi: 10.1155/2021/2271514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/2271514</ArticleId><ArticleId IdType="pmc">PMC8443384</ArticleId><ArticleId IdType="pubmed">34539780</ArticleId></ArticleIdList></Reference><Reference><Citation>De Almeida C.A.P., Guimarães M.R., De Oliveira M.F.A., Seabra V., Smolentzov I., Reichert B.V., Lins P.R.G., Rodrigues C.E., da Conceição Andrade L. Is there a link between COVID-19 and adrenal insufficiency? J. Nephrol. 2022;36:617–619. doi: 10.1007/s40620-022-01431-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-022-01431-9</ArticleId><ArticleId IdType="pmc">PMC9396593</ArticleId><ArticleId IdType="pubmed">35997938</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayaz S.M.H.D., Zargaz S.E.H., Ziaee M., Soroosh Z., Babaiyan S. Adrenal Insufficiency in Patients with COVID-19. Shiraz E-Med. J. 2023.  [(accessed on 11 June 2024)].  
in press
. Available online:  https://brieflands.com/articles/semj-136950.html.</Citation></Reference><Reference><Citation>Alzahrani A.S., Mukhtar N., Aljomaiah A., Aljamei H., Bakhsh A., Alsudani N., Elsayed T., Alrashidi N., Fadel R., Alqahtani E., et al. The Impact of COVID-19 Viral Infection on the Hypothalamic-Pituitary-Adrenal Axis. Endocr. Pract. 2021;27:83–89. doi: 10.1016/j.eprac.2020.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eprac.2020.10.014</ArticleId><ArticleId IdType="pmc">PMC7837186</ArticleId><ArticleId IdType="pubmed">33554871</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan T., Khoo B., Mills E.G., Phylactou M., Patel B., Eng P.C., Thurston L., Muzi B., Meeran K., Prevost A.T., et al. Association between high serum total cortisol concentrations and mortality from COVID-19. Lancet Diabetes Endocrinol. 2020;8:659–660. doi: 10.1016/S2213-8587(20)30216-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30216-3</ArticleId><ArticleId IdType="pmc">PMC7302794</ArticleId><ArticleId IdType="pubmed">32563278</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckley T.M., Schatzberg A.F. On the Interactions of the Hypothalamic-Pituitary-Adrenal (HPA) Axis and Sleep: Normal HPA Axis Activity and Circadian Rhythm, Exemplary Sleep Disorders. J. Clin. Endocrinol. Metab. 2005;90:3106–3114. doi: 10.1210/jc.2004-1056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2004-1056</ArticleId><ArticleId IdType="pubmed">15728214</ArticleId></ArticleIdList></Reference><Reference><Citation>Petramala L., Olmati F., Conforti M.G., Concistré A., Bisogni V., Alfieri N., Iannucci G., de Toma G., Letizia C. Autoimmune Diseases in Patients with Cushing’s Syndrome after Resolution of Hypercortisolism: Case Reports and Literature Review. Int. J. Endocrinol. 2018;2018:1–7. doi: 10.1155/2018/1464967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/1464967</ArticleId><ArticleId IdType="pmc">PMC6312625</ArticleId><ArticleId IdType="pubmed">30662460</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilias I., Vassiliou A.G., Keskinidou C., Vrettou C.S., Orfanos S., Kotanidou A., Dimopoulou I. Changes in Cortisol Secretion and Corticosteroid Receptors in COVID-19 and Non COVID-19 Critically Ill Patients with Sepsis/Septic Shock and Scope for Treatment. Biomedicines. 2023;11:1801. doi: 10.3390/biomedicines11071801.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11071801</ArticleId><ArticleId IdType="pmc">PMC10376106</ArticleId><ArticleId IdType="pubmed">37509441</ArticleId></ArticleIdList></Reference><Reference><Citation>Świątkowska-Stodulska R., Berlińska A., Puchalska-Reglińska E. Cortisol as an Independent Predictor of Unfavorable Outcomes in Hospitalized COVID-19 Patients. Biomedicines. 2022;10:1527. doi: 10.3390/biomedicines10071527.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10071527</ArticleId><ArticleId IdType="pmc">PMC9313159</ArticleId><ArticleId IdType="pubmed">35884833</ArticleId></ArticleIdList></Reference><Reference><Citation>Giovanella L., Ruggeri R.M., Ovčariček P.P., Campenni A., Treglia G., Deandreis D. Prevalence of thyroid dysfunction in patients with COVID-19: A systematic review. Clin. Transl. Imaging. 2021;9:233–240. doi: 10.1007/s40336-021-00419-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40336-021-00419-y</ArticleId><ArticleId IdType="pmc">PMC7950424</ArticleId><ArticleId IdType="pubmed">33728279</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller I., Cannavaro D., Dazzi D., Covelli D., Mantovani G., Muscatello A., Ferrantea E., Orsia E., Resia V., Longari V., et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020;8:739–741. doi: 10.1016/S2213-8587(20)30266-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30266-7</ArticleId><ArticleId IdType="pmc">PMC7392564</ArticleId><ArticleId IdType="pubmed">32738929</ArticleId></ArticleIdList></Reference><Reference><Citation>Lania A., Sandri M.T., Cellini M., Mirani M., Lavezzi E., Mazziotti G. Thyrotoxicosis in patients with COVID-19: The THYRCOV study. Eur. J. Endocrinol. 2020;183:381–387. doi: 10.1530/EJE-20-0335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0335</ArticleId><ArticleId IdType="pmc">PMC9494315</ArticleId><ArticleId IdType="pubmed">32698147</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanachkova V., Stankova T., Staynova R. Thyroid dysfunction as a long-term post-COVID-19 complication in mild-to-moderate COVID-19. Biotechnol. Biotechnol. Equip. 2023;37:194–202. doi: 10.1080/13102818.2023.2170829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13102818.2023.2170829</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W., Guo W., Guo Y., Shi M., Dong G., Wang G., Ge Q., Zhu J., Zhou X. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J. Endocrinol. Investig. 2021;44:1031–1040. doi: 10.1007/s40618-020-01460-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01460-w</ArticleId><ArticleId IdType="pmc">PMC7605732</ArticleId><ArticleId IdType="pubmed">33140379</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gerwen M., Alsen M., Little C., Barlow J., Naymagon L., Tremblay D., Sinclair C.F., Genden E. Outcomes of Patients With Hypothyroidism and COVID-19: A Retrospective Cohort Study. Front. Endocrinol. 2020;11:565. doi: 10.3389/fendo.2020.00565.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.00565</ArticleId><ArticleId IdType="pmc">PMC7461836</ArticleId><ArticleId IdType="pubmed">33013686</ArticleId></ArticleIdList></Reference><Reference><Citation>Feghali K., Atallah J., Norman C. Manifestations of thyroid disease post COVID-19 illness: Report of Hashimoto thyroiditis, Graves’ disease, and subacute thyroiditis. J. Clin. Transl. Endocrinol. Case Rep. 2021;22:100094. doi: 10.1016/j.jecr.2021.100094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jecr.2021.100094</ArticleId><ArticleId IdType="pmc">PMC8387132</ArticleId><ArticleId IdType="pubmed">34462717</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliers E., Boelen A. An update on non-thyroidal illness syndrome. J. Endocrinol. Investig. 2021;44:1597–1607. doi: 10.1007/s40618-020-01482-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01482-4</ArticleId><ArticleId IdType="pmc">PMC8285315</ArticleId><ArticleId IdType="pubmed">33320308</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Farwell A.P. Euthyroid Sick Syndrome. Compr. Physiol. 2016;6:1071–1080.</Citation><ArticleIdList><ArticleId IdType="pubmed">27065175</ArticleId></ArticleIdList></Reference><Reference><Citation>DeGroot L.J.  The Non-Thyroidal Illness Syndrome. In: Feingold K.R., Anawalt B., Blackman M.R., Boyce A., Chrousos G., Corpas E., de Herder W.W., Dhatariya K., Dungan K., Hofland J., et al., editors. Endotext [Internet] MDText.com, Inc.; South Dartmouth, MA, USA: 2000.  [(accessed on 24 August 2024)].  Available online:  http://www.ncbi.nlm.nih.gov/books/NBK285570/</Citation></Reference><Reference><Citation>Boelaert K., Visser W.E., Taylor P.N., Moran C., Léger J., Persani L. Endocrinology in the time of COVID-19: Management of hyperthyroidism and hypothyroidism. Eur. J. Endocrinol. 2020;183:G33–G39. doi: 10.1530/EJE-20-0445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0445</ArticleId><ArticleId IdType="pmc">PMC7938012</ArticleId><ArticleId IdType="pubmed">32438340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleebayoon A., Wiwanitkit V. COVID-19 Vaccine, Safety in a Case with Underlying Pituitary Adenoma. Neurol. India. 2023;71:1076. doi: 10.4103/0028-3886.388052.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0028-3886.388052</ArticleId><ArticleId IdType="pubmed">37929478</ArticleId></ArticleIdList></Reference><Reference><Citation>Verrienti M., Picciola V.M., Ambrosio M.R., Zatelli M.C. Pituitary and COVID-19 vaccination: A systematic review. Pituitary. 2024 doi: 10.1007/s11102-024-01402-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11102-024-01402-2</ArticleId><ArticleId IdType="pubmed">38761322</ArticleId></ArticleIdList></Reference><Reference><Citation>Taieb A., Nassim B.H.S., Asma G., Jabeur M., Ghada S., Asma B.A. The Growing Understanding of the Pituitary Implication in the Pathogenesis of Long COVID-19 Syndrome: A Narrative Review. Adv. Respir. Med. 2024;92:96–109. doi: 10.3390/arm92010013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/arm92010013</ArticleId><ArticleId IdType="pmc">PMC10886368</ArticleId><ArticleId IdType="pubmed">38392036</ArticleId></ArticleIdList></Reference><Reference><Citation>Taieb A., Mounira E.E. Pilot Findings on SARS-CoV-2 Vaccine-Induced Pituitary Diseases: A Mini Review from Diagnosis to Pathophysiology. Vaccines. 2022;10:2004. doi: 10.3390/vaccines10122004.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10122004</ArticleId><ArticleId IdType="pmc">PMC9786744</ArticleId><ArticleId IdType="pubmed">36560413</ArticleId></ArticleIdList></Reference><Reference><Citation>Urhan E., Karaca Z., Unuvar G.K., Gundogan K., Unluhizarci K. Investigation of pituitary functions after acute coronavirus disease 2019. Endocr. J. 2022;69:649–658. doi: 10.1507/endocrj.EJ21-0531.</Citation><ArticleIdList><ArticleId IdType="doi">10.1507/endocrj.EJ21-0531</ArticleId><ArticleId IdType="pubmed">34987144</ArticleId></ArticleIdList></Reference><Reference><Citation>Rashmi K.G., Perumal N., Cherian A., Wyawahare M., Prasad A., Sahoo J., Kamalanathan S.K., Anusuya R., Naik D. Hypothalamic-Pituitary Adrenal Axis Status 3 Months After Recovery From COVID-19 Infection. Endocr. Res. 2023;48:85–93.</Citation><ArticleIdList><ArticleId IdType="pubmed">37565765</ArticleId></ArticleIdList></Reference><Reference><Citation>Saba L., Hanna C., Creo A.L. Updates in hyponatremia and hypernatremia. Curr. Opin. Pediatr. 2024;36:219–227. doi: 10.1097/MOP.0000000000001324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOP.0000000000001324</ArticleId><ArticleId IdType="pubmed">38174733</ArticleId></ArticleIdList></Reference><Reference><Citation>Spasovski G., Vanholder R., Allolio B., Annane D., Ball S., Bichet D., Decaux G., Fenske W., Hoorn E.J., Ichai C., et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur. J. Endocrinol. 2014;170:G1–G47. doi: 10.1530/EJE-13-1020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-13-1020</ArticleId><ArticleId IdType="pubmed">24569125</ArticleId></ArticleIdList></Reference><Reference><Citation>Alosaimi M.M., Hassan H. Hyponatremia, a Concise Practical Review.  [(accessed on 19 June 2024)];Curr. Trends Intern. Med. 2024 8:214. Available online:  https://www.gavinpublishers.com/article/view/hyponatremia-a-concise-practical-review.</Citation></Reference><Reference><Citation>Khan F.G., Sattar S., Yaqoob M.M., Vallani N., Asad M. Frequency of dysnatremia in patients admitted with COVID-19 infection and its prognostic implication. J. Int. Med. Res. 2023;51:03000605231202180. doi: 10.1177/03000605231202180.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03000605231202180</ArticleId><ArticleId IdType="pmc">PMC10631357</ArticleId><ArticleId IdType="pubmed">37933974</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Mowrey W., Fisher M., Basalely A., McCarthy J., Kumar N., Thakkar J., Azzi Y., Brogan M., Golestaneh L., et al. Associations of Dysnatremia with COVID-19 Status and Mortality. Kidney360. 2022;3:1323–1331. doi: 10.34067/KID.0001062022.</Citation><ArticleIdList><ArticleId IdType="doi">10.34067/KID.0001062022</ArticleId><ArticleId IdType="pmc">PMC9416846</ArticleId><ArticleId IdType="pubmed">36176656</ArticleId></ArticleIdList></Reference><Reference><Citation>Królicka A., Letachowicz K., Adamik B., Doroszko A., Kaliszewski K., Kiliś-Pstrusińska K., Kujawa K., Matera-Witkiewicz A., Madziarski M., Pomorski M., et al. Dysnatremia in COVID-19 Patients—An Analysis of the COLOS Study. J. Clin. Med. 2023;12:2802. doi: 10.3390/jcm12082802.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12082802</ArticleId><ArticleId IdType="pmc">PMC10140822</ArticleId><ArticleId IdType="pubmed">37109139</ArticleId></ArticleIdList></Reference><Reference><Citation>Núñez-Martínez F.J., Orozco-Juárez K., Chávez-Lárraga A.J., Velasco-Santos J.I. Disnatremias y su asociación con morbimortalidad en pacientes con COVID-19 [Dysnatremias and their association with morbidity and mortality in patients with COVID-19] Rev. Med. Inst. Mex. Seguro Soc. 2022;60:548–555. (In Spanish)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10396052</ArticleId><ArticleId IdType="pubmed">36048807</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino M., Falcioni P., Giancola G., Ciarloni A., Salvio G., Silvetti F., Taccaliti A., Arnaldi G. Sodium alterations impair the prognosis of hospitalized patients with COVID-19 pneumonia. Endocr. Connect. 2021;10:1344–1351. doi: 10.1530/EC-21-0411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-21-0411</ArticleId><ArticleId IdType="pmc">PMC8558885</ArticleId><ArticleId IdType="pubmed">34533476</ArticleId></ArticleIdList></Reference><Reference><Citation>Voets P.J., Frölke S.C., Vogtländer N.P., Kaasjager K.A. COVID-19 and dysnatremia: A comparison between COVID-19 and non-COVID-19 respiratory illness. SAGE Open Med. 2021;9:20503121211027778. doi: 10.1177/20503121211027778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20503121211027778</ArticleId><ArticleId IdType="pmc">PMC8252341</ArticleId><ArticleId IdType="pubmed">34262763</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzoulis P., Grossman A.B., Baldeweg S.E., Bouloux P., Kaltsas G. MANAGEMENT OF ENDOCRINE DISEASE: Dysnatraemia in COVID-19: Prevalence, prognostic impact, pathophysiology, and management. Eur. J. Endocrinol. 2021;185:R103–R111. doi: 10.1530/EJE-21-0281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-21-0281</ArticleId><ArticleId IdType="pmc">PMC8428074</ArticleId><ArticleId IdType="pubmed">34370712</ArticleId></ArticleIdList></Reference><Reference><Citation>Atila C., Sailer C.O., Bassetti S., Tschudin-Sutter S., Bingisser R., Siegemund M., Osswald S., Rentsch K., Rueegg M., Schaerli S., et al. Prevalence and outcome of dysnatremia in patients with COVID-19 compared to controls. Eur. J. Endocrinol. 2021;184:409–418. doi: 10.1530/EJE-20-1374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-1374</ArticleId><ArticleId IdType="pmc">PMC9494345</ArticleId><ArticleId IdType="pubmed">33449918</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Sánchez J.G., Núñez-Gil I.J., Cuesta M., Rubio M.A., Maroun-Eid C., Arroyo-Espliguero R., Romero R., Becerra-Muñoz V.M., Uribarri A., Feltes G., et al. Prognostic Impact of Hyponatremia and Hypernatremia in COVID-19 Pneumonia. A HOPE-COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry Analysis. Front. Endocrinol. 2020;11:599255. doi: 10.3389/fendo.2020.599255.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2020.599255</ArticleId><ArticleId IdType="pmc">PMC7734292</ArticleId><ArticleId IdType="pubmed">33329400</ArticleId></ArticleIdList></Reference><Reference><Citation>Berni A., Malandrino D., Corona G., Maggi M., Parenti G., Fibbi B., Poggesi L., Bartoloni A., Lavorini F., Fanelli A., et al. Serum sodium alterations in SARS-CoV-2 (COVID-19) infection: Impact on patient outcome. Eur. J. Endocrinol. 2021;185:137–144. doi: 10.1530/EJE-20-1447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-1447</ArticleId><ArticleId IdType="pmc">PMC9494309</ArticleId><ArticleId IdType="pubmed">33950864</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera J.A., Valdes E., Huang J.M., Lewis A., Lord A.S., Zhou T., Kahn D.E.D., Melmed K., Czeisler B.M., Yaghi S., et al. Prevalence and Impact of Hyponatremia in Patients With Coronavirus Disease 2019 in New York City. Crit. Care Med. 2020;48:e1211–e1217. doi: 10.1097/CCM.0000000000004605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004605</ArticleId><ArticleId IdType="pmc">PMC7467047</ArticleId><ArticleId IdType="pubmed">32826430</ArticleId></ArticleIdList></Reference><Reference><Citation>Khidir R.J.Y., Ibrahim B.A.Y., Adam M.H.M., Hassan R.M.E., Fedail A.S.S., Abdulhamid R.O., Mohamed S.O.O. Prevalence and outcomes of hyponatremia among COVID-19 patients: A systematic review and meta-analysis. Int. J. Health Sci. 2022;16:69–84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9441642</ArticleId><ArticleId IdType="pubmed">36101848</ArticleId></ArticleIdList></Reference><Reference><Citation>Hata T., Goto T., Yamanaka S., Matsumoto T., Yamamura O., Hayashi H. Prognostic value of initial serum sodium level in predicting disease severity in patients with COVID-19: A multicenter retrospective study. J. Infect. Chemother. 2024;30:181–187. doi: 10.1016/j.jiac.2023.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiac.2023.10.002</ArticleId><ArticleId IdType="pubmed">37802152</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow M.K., Kwek D.S., Ng A.W., Ong K., Kaw G.J., Lee L.S. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS) Clin. Endocrinol. 2005;63:197–202. doi: 10.1111/j.1365-2265.2005.02325.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2265.2005.02325.x</ArticleId><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasir M., Mechanic O.J.  Syndrome of Inappropriate Antidiuretic Hormone Secretion. StatPearls Publishing; Treasure Island, FL, USA: 2024.  [(accessed on 23 May 2024)].  Available online:  http://www.ncbi.nlm.nih.gov/books/NBK507777/</Citation><ArticleIdList><ArticleId IdType="pubmed">29939554</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousaf Z., Al-Shokri S.D., Al-soub H., Mohamed M.F.H. COVID-19-associated SIADH: A clue in the times of pandemic! Am. J. Physiol.-Endocrinol. Metab. 2020;318:E882–E885. doi: 10.1152/ajpendo.00178.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00178.2020</ArticleId><ArticleId IdType="pmc">PMC7276977</ArticleId><ArticleId IdType="pubmed">32396497</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh M.M., Ahmad E., Jeelani H.M., Riaz A., Muneeb A. COVID-19 Pneumonia: An Emerging Cause of Syndrome of Inappropriate Antidiuretic Hormone. Cureus. 2020;12:e8841. doi: 10.7759/cureus.8841.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.8841</ArticleId><ArticleId IdType="pmc">PMC7386090</ArticleId><ArticleId IdType="pubmed">32754385</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez J.A., Ritzenthaler D., Sawaya A., Pensiero A.L. Severe Hyponatremia in the Setting of COVID-19-Associated Syndrome of Inappropriate Antidiuretic Hormone: A Case Report. Cureus. 2023;15:e33330. doi: 10.7759/cureus.33330.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.33330</ArticleId><ArticleId IdType="pmc">PMC9897715</ArticleId><ArticleId IdType="pubmed">36751173</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. doi: 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R., Zhao X., Li J., Niu P., Yang B., Wu H., Wang W., Song H., Huang B., Zhu N., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020;395:565–574. doi: 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Atila C., Monnerat S., Bingisser R., Siegemund M., Lampart M., Rueegg M., Zellweger N., Osswald S., Rentsch K., Christ-Crain M., et al. Inverse relationship between IL-6 and sodium levels in patients with COVID-19 and other respiratory tract infections: Data from the COVIVA study. Endocr. Connect. 2022;11:e220171. doi: 10.1530/EC-22-0171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-22-0171</ArticleId><ArticleId IdType="pmc">PMC9578076</ArticleId><ArticleId IdType="pubmed">36006851</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman M.N., Pearce B.D., Biron C.A., Miller A.H. Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol. 2005;18:41–78. doi: 10.1089/vim.2005.18.41.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2005.18.41</ArticleId><ArticleId IdType="pmc">PMC1224723</ArticleId><ArticleId IdType="pubmed">15802953</ArticleId></ArticleIdList></Reference><Reference><Citation>Durcan E., Hacioglu A., Karaca Z., Unluhizarci K., Gonen M.S., Kelestimur F. Hypothalamic-Pituitary Axis Function and Adrenal Insufficiency in COVID-19 Patients. Neuroimmunomodulation. 2023;30:215–225. doi: 10.1159/000534025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000534025</ArticleId><ArticleId IdType="pmc">PMC10614450</ArticleId><ArticleId IdType="pubmed">37703857</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamazaki K., Nishigaki T., Kuramoto N., Oh K., Konishi H. Secondary Adrenal Insufficiency After COVID-19 Diagnosed by Insulin Tolerance Test and Corticotropin-Releasing Hormone Test. Cureus. 2022;14:e23021. doi: 10.7759/cureus.23021.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.23021</ArticleId><ArticleId IdType="pmc">PMC8908067</ArticleId><ArticleId IdType="pubmed">35281581</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M., Zhou W., Xu W. Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study. Thyroid. 2021;31:8–11. doi: 10.1089/thy.2020.0363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/thy.2020.0363</ArticleId><ArticleId IdType="pubmed">32600165</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaduganathan M., Vardeny O., Michel T., McMurray J.J.V., Pfeffer M.A., Solomon S.D. Renin–Angiotensin–Aldosterone System Inhibitors in Patients with COVID-19. N. Engl. J. Med. 2020;382:1653–1659. doi: 10.1056/NEJMsr2005760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr2005760</ArticleId><ArticleId IdType="pmc">PMC7121452</ArticleId><ArticleId IdType="pubmed">32227760</ArticleId></ArticleIdList></Reference><Reference><Citation>Ata F., Almasri H., Sajid J., Yousaf Z. COVID-19 presenting with diarrhoea and hyponatraemia. BMJ Case Rep. 2020;13:e235456. doi: 10.1136/bcr-2020-235456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-235456</ArticleId><ArticleId IdType="pmc">PMC10577739</ArticleId><ArticleId IdType="pubmed">32513768</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray E.C., Rondon-Berrios H., Boyd C.R., Kleyman T.R. Sodium retention and volume expansion in nephrotic syndrome: Implications for hypertension. Adv. Chronic Kidney Dis. 2015;22:179–184. doi: 10.1053/j.ackd.2014.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ackd.2014.11.006</ArticleId><ArticleId IdType="pmc">PMC4409655</ArticleId><ArticleId IdType="pubmed">25908466</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourfridoni M., Abbasnia S.M., Shafaei F., Razaviyan J., Heidari-Soureshjani R. Fluid and Electrolyte Disturbances in COVID-19 and Their Complications. BioMed Res. Int. 2021;2021:1–5. doi: 10.1155/2021/6667047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6667047</ArticleId><ArticleId IdType="pmc">PMC8060100</ArticleId><ArticleId IdType="pubmed">33937408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Li X.-Y. Prevalence of hyponatremia among older inpatients in a general hospital. Eur. Geriatr. Med. 2020;11:685–692. doi: 10.1007/s41999-020-00320-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41999-020-00320-3</ArticleId><ArticleId IdType="pmc">PMC7438367</ArticleId><ArticleId IdType="pubmed">32372184</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q., Zhang L., et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215–220. doi: 10.1038/s41586-020-2180-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2180-5</ArticleId><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner G., Funk G.-C. Hypernatremia in critically ill patients. J. Crit. Care. 2013;28:216.e11–216.e20. doi: 10.1016/j.jcrc.2012.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2012.05.001</ArticleId><ArticleId IdType="pubmed">22762930</ArticleId></ArticleIdList></Reference><Reference><Citation>So B.Y.F., Wong C.K., Chan G.C.K., Ng J.K.C., Lui G.C.Y., Szeto C.C., Hung I.F.N., Tse H.F., Tang S.C.W., Chan T.M., et al. Epidemiology and Outcomes of Hypernatraemia in Patients with COVID-19—A Territory-Wide Study in Hong Kong. J. Clin. Med. 2023;12:1042. doi: 10.3390/jcm12031042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12031042</ArticleId><ArticleId IdType="pmc">PMC9918136</ArticleId><ArticleId IdType="pubmed">36769690</ArticleId></ArticleIdList></Reference><Reference><Citation>Habas E., Ali E., Habas A., Rayani A., Ghazouani H., Khan F., Khalifa F., Abdel-Nasser E. Hyponatremia and SARS-CoV-2 infection: A narrative review. Medicine. 2022;101:e30061. doi: 10.1097/MD.0000000000030061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000030061</ArticleId><ArticleId IdType="pmc">PMC9370252</ArticleId><ArticleId IdType="pubmed">35960124</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng P.Y., Cheung R.Y.T., Ip A., Chan W.M., Sin W.C., Yap D.Y.H. A retrospective cohort study on the clinical outcomes of patients admitted to intensive care units with dysnatremia. Sci. Rep. 2023;13:21236. doi: 10.1038/s41598-023-48399-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-48399-5</ArticleId><ArticleId IdType="pmc">PMC10692105</ArticleId><ArticleId IdType="pubmed">38040748</ArticleId></ArticleIdList></Reference><Reference><Citation>Falchi A.G., Mascolo C., Sepe V., Libetta C., Bonadeo E., Albertini R., Manzoni F., Perlini S. Hyponatremia as a predictor of outcome and mortality: Results from a second-level urban emergency department population. Ir. J. Med. Sci. 2023;192:389–393. doi: 10.1007/s11845-022-02953-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-022-02953-8</ArticleId><ArticleId IdType="pubmed">35187606</ArticleId></ArticleIdList></Reference><Reference><Citation>Valle J.M., Beveridge A., Chróinín D.N. Exploring hyponatremia in older hospital in-patients: Management, association with falls, and other adverse outcomes. Aging Health Res. 2022;2:100060. doi: 10.1016/j.ahr.2022.100060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahr.2022.100060</ArticleId></ArticleIdList></Reference><Reference><Citation>Parajuli S., Tiwari S., Gupta S.K., Shakya Y.M., Shakya Y.L. Hyponatremia in Patients Admitted to Intensive Care Unit of a Tertiary Center: A Descriptive Cross-sectional Study. J. Nepal Med. Assoc. 2022;60:935–938. doi: 10.31729/jnma.7123.</Citation><ArticleIdList><ArticleId IdType="doi">10.31729/jnma.7123</ArticleId><ArticleId IdType="pmc">PMC9795098</ArticleId><ArticleId IdType="pubmed">36705183</ArticleId></ArticleIdList></Reference><Reference><Citation>Rondon-Berrios H., Velez J.C.Q. Hyponatremia in Cirrhosis. Clin. Liver Dis. 2022;26:149–164. doi: 10.1016/j.cld.2022.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cld.2022.01.001</ArticleId><ArticleId IdType="pmc">PMC9060324</ArticleId><ArticleId IdType="pubmed">35487602</ArticleId></ArticleIdList></Reference><Reference><Citation>Saepudin S., Ball P.A., Morrissey H. Hyponatremia during hospitalization and in-hospital mortality in patients hospitalized from heart failure. BMC Cardiovasc. Disord. 2015;15:88. doi: 10.1186/s12872-015-0082-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-015-0082-5</ArticleId><ArticleId IdType="pmc">PMC4542119</ArticleId><ArticleId IdType="pubmed">26271263</ArticleId></ArticleIdList></Reference><Reference><Citation>Edmonds Z.V. Hyponatremia in pneumonia. J. Hosp. Med. 2012;7((Suppl. 4)):S11–S13. doi: 10.1002/jhm.1933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jhm.1933</ArticleId><ArticleId IdType="pubmed">22489080</ArticleId></ArticleIdList></Reference><Reference><Citation>Potasso L., Sailer C.O., Blum C.A., Cesana-Nigro N., Schuetz P., Mueller B., Christ-Crain M. Mild to moderate hyponatremia at discharge is associated with increased risk of recurrence in patients with community-acquired pneumonia. Eur. J. Intern. Med. 2020;75:44–49. doi: 10.1016/j.ejim.2019.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2019.12.009</ArticleId><ArticleId IdType="pubmed">31952985</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>